PharmaEngine, Inc. (TWO: 4162) announced that the Taiwan Food and Drug Administration (TFDA) has approved ONIVYDETM (irinotecan liposome injection) in ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Merrimack (MACK) Onivyde Labeling Appears as Expected, Says Mizuho SecuritiesOctober 22, 2015 2:14 PM Merrimack Pharma (MACK) Drops Lower Following ONIVYDE Approval; Will Include 'Boxed Warning'October 22, 2015 2:10 PM Merrimack Pharma (MACK) to Resume Trading at 1:40 PM EDTOctober 22, 2015 1:32 PM FDA Approves Merrimack Pharma's (MACK) ONIVYDEOctober 22, 2015 11:32 AM